Tag:
AmerisourceBergen
Latest Headlines
Latest Headlines
Congress probes whether small wholesalers are gouging drug prices
Congress is investigating whether some small drug wholesalers are gaming the system by setting up their own pharmacies to get their hands on drugs in short supply.
AmerisourceBergen buys another pharmaceutical services company
Drug wholesaler AmerisourceBergen ( $ABC ) is extending its acquisition binge, this time with the $520 million cash acquisition of World Courier Group.
Cardinal and McKesson positive, upbeat on financials
Drug distributors Cardinal Health ( $CAH ) and McKesson ( $MCK ) each reported positive financials for the last fiscal quarter and say they are upbeat about the future. Cardinal credits its generics
Specialty drugs come to Big Pharma's rescue
Specialty drugs are in the news again this week. A Reuters report quotes Sanofi CEO Chris Viehbacher ( photo ) as saying the mass market for drugs "is really starting to disappear." That's very likely
Big 3 distribs hold big pharma survival clues
Speaking of business transformation [ see related story ], an op-ed writer in Forbes says that behavior of the big three drug distributors may model behavior that big pharma can adopt during these
ABC, Cardinal see growth in specialty pharma
AmerisourceBergen CEO-in waiting Steve Collis, likely successor in July to the retiring Dave Yost, sees a future in staying the course with a focus on specialty distribution and generics. Specialty
ALSO NOTED: Novartis cuts malaria drug price; India bars Cipla from exporting Tarceva copy;
> Novartis is slashing the public-sector price of its antimalarial med Coartem by 20 percent, to 80 cents from $1, to make the treatment more widely available.
ALSO NOTED: AmerisourceBergen buys Bellco Health for $300M; UCB, Sanofi ship new allergy med Xycal;
> Pharma services company AmerisourceBergen completed its purchase of Bellco Health, a privately held drug distributor, for a cash price of about $190 million.
OneOncology aims for better drug prices
Bookstores do it. Mom-and-Pop grocers do it. Why shouldn't oncologists do it? Small oncology practices are banding together to get better prices for expensive cancer drugs, thanks to a new drug
